Z. Xm, Y. Li, Jiao Yf, Bao Zg, Liu Xh, Chen Tw, H. Xh, L. Yang
{"title":"Pancreatic Carcinoma with the First Symptom of Acute Pancreatitis: MRI Findings and Clinical Features","authors":"Z. Xm, Y. Li, Jiao Yf, Bao Zg, Liu Xh, Chen Tw, H. Xh, L. Yang","doi":"10.4172/2165-7092.1000132","DOIUrl":"https://doi.org/10.4172/2165-7092.1000132","url":null,"abstract":"Purpose: To study the MRI findings and clinical features of pancreatic carcinoma with the first symptom of acute pancreatitis. \u0000Materials and Methods: Twelve patients with pancreatic carcinoma and the first symptom of acute pancreatitis were included in this study. Pancreatic carcinoma with acute pancreatitis was confirmed by pathology. The MRI findings and clinical features of pancreatic carcinoma combined with acute pancreatitis were noted. \u0000Results: In the 12 patients with acute pancreatitis, the pancreas appeared edematous and non-necrotic on MRI. The pancreatic carcinomas were mainly located in the head of the pancreas (83.33%, 10/12). Most patients showed a mass on T1-weighted and T2-weighted images. A dilated pancreatic duct and/or Common Bile Duct (CBD) was observed on MRI of 75% (9/12) of the patients. The results of laboratory tests demonstrated increased CA19-9 in 8 of the patients (66.67%), elevation of both ALP and AST in 11 of the patients (91.67%), and normal ALP and AST levels in 1 patient. \u0000Conclusions: Acute pancreatitis may be an indicator of pancreatic carcinoma. A pancreatic mass and a dilated pancreatic duct and/or CBD observed by MRI can provide evidence of the associated pancreatic carcinoma. Increased levels of ALT, AST or ALP and CA19-9 may aid the diagnosis of pancreatic carcinoma in cases of acute pancreatitis.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"16 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2014-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82455191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Extrapancreatic Solid Pseudopapillary Neoplasm in the Subhepatic Region: A Diagnostic Dilemma","authors":"Rifat Mannan Aas, Songyang Yuan","doi":"10.4172/2165-7092.1000152","DOIUrl":"https://doi.org/10.4172/2165-7092.1000152","url":null,"abstract":"Solid pseudopapillary neoplasm (SPN) is a rare but distinctive pancreatic neoplasm that typically affects young women. Rare cases of extrapancreatic SPN have been reported. Here; we present an unusual case of SPN in a 32- year-old woman who presented with vague abdominal pain. Computed tomography scan revealed a large solid mass in the subhepatic region; adjacent to the head of pancreas and second part of duodenum. The pancreatic gland parenchyma was not involved. Radiologic features were suggestive of a gastrointestinal stromal tumor. On microscopic examination, the lesion exhibited both solid and pseudopapillary pattern with prominent myxoid change in the stroma. Immunohistochemistry showed strong expression of vimentin, CD10, CD56 and alpha 1 antitrypsin. Synaptophysin was focally positive. β-catenin immunostain showed strong nuclear expression; while stain for Ecadherin was negative. Stains for cytokeratin;epithelial membrane antigen; chromogranin A; calretinin; carcinoembryonic antigen and S-100 protein were negative. These morphologic and immunohistochemical features were characteristic of SPN. We present this case to highlight the importance of recognizing SPN at an unusual location. Differentiation from neuroendocrine tumor can be particularly challenging due to their overlapping clinical; radiologic; morphologic and immunohistochemical features.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"102 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2014-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75806908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Multiple Hydatid Cysts of the Pancreas: A Literature First","authors":"Senthil Kumar, S. Bramhall, I. Scalera","doi":"10.4172/2165-7092.1000130","DOIUrl":"https://doi.org/10.4172/2165-7092.1000130","url":null,"abstract":"Context: Pancreatic hydatid disease is rare, occurring in less than 2% of all patients with hydatid disease. Multiple hydatid cysts of the pancreas have not been reported before. \u0000Case report: A 63 year old lady presented with chronic epigastric pain without weight loss, vomiting or jaundice. CT scan revealed multiple small cystic pancreatic lesions. There was no extra-pancreatic disease. Endoscopic ultrasound showed 10 cysts distributed throughout the pancreas with the largest being 1.3 cm. The aspirated fluid was mucin free, low in amylase and CEA. FNAC showed refractile structures and membranous remnants consistent with a hydatid cyst. The cyst distribution would have warranted a total pancreatectomy for complete extirpation. As the cysts were uncomplicated and relatively asymptomatic, a conservative non-operative approach was chosen. She has shown symptomatic improvement and has stable disease after 6 months with Albendazole treatment. \u0000Conclusion: Endoscopic ultrasound is useful in the diagnosis of pancreatic hydatid disease. In selected cases, non-operative management is an option that needs to be considered.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"3 1","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2014-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85005899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Peripancreatic Fluid Collections: A Review","authors":"J. Goyal","doi":"10.4172/2165-7092.1000131","DOIUrl":"https://doi.org/10.4172/2165-7092.1000131","url":null,"abstract":"Peripancreatic fluid collections arise as a complication of pancreatitis and pancreatic injury. Surgery has been the traditional treatment modality of choice for management of peripancreatic fluid collections though endoscopic, laparoscopic and transcutaneous techniques offer alternative drainage approaches. Endoscopic ultrasound has enabled real-time access and drainage of fluid collections which were previously not amenable to transmural drainage. There is limited data from randomized clinical trials including that on direct comparisons between different treatment approaches. In this review, we have summarized the existing evidence on endoscopic drainage of peripancreatic fluid collections from published studies. The final treatment approach should be chosen taking into consideration anatomic characteristics, patient preference, comorbidity profile of the patient, and physician discretion.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"17 2","pages":"1-12"},"PeriodicalIF":0.0,"publicationDate":"2014-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72581090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Makris, Nikolaos M Kourkounakis, I. Karoumpalis, Konstantinos C Koumarelas, A. Mitrousias, M. Kornaropoulos, Dimitris Katsogiannos, E. Yettimis
{"title":"An IPMN Inside a Serous Cystadenoma: Is That Possible?","authors":"M. Makris, Nikolaos M Kourkounakis, I. Karoumpalis, Konstantinos C Koumarelas, A. Mitrousias, M. Kornaropoulos, Dimitris Katsogiannos, E. Yettimis","doi":"10.4172/2165-7092.1000129","DOIUrl":"https://doi.org/10.4172/2165-7092.1000129","url":null,"abstract":"Abstract Objectives: Although rare, the pancreatic cystic neoplasms are detected with increased frequency lately. The treatment of these modalities however remains controversial. Methods: In this case reports a multifocal Intraductal Papillary Mucinous Neoplasm (IPMN) along with Pancreatic Serous Cystadenoma (PSC) were identified in the pancreatic specimen following a distal pancreatectomy. The results of the histopathology confirmed the existence of an IPMN inside a large PSC. Results: In our case, the patient with this extremely rare type of mixed cystic neoplasm was managed successfully with extensive distal pancreatectomy. Conclusions: The preoperative evaluation of the extent of the pancreatic involvement and the definition of the histologic type of the involved neoplasms before the pancreatic resection is challenging.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"18 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2014-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83777486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sukharamwala Prashant, Thoens Jonathan, S. Mauricio, P. Neil, O. Dennis, Ghani N Abdul, D. Peter
{"title":"A Meta-Analysis and Systematic Review of Pancreatic Duct Stent","authors":"Sukharamwala Prashant, Thoens Jonathan, S. Mauricio, P. Neil, O. Dennis, Ghani N Abdul, D. Peter","doi":"10.4172/2165-7092.1000128","DOIUrl":"https://doi.org/10.4172/2165-7092.1000128","url":null,"abstract":"Abstract \u0000Background: Two methods of pancreatic duct decompression following pancreaticoduodenectomy (PD) are currently employed, the internal and external pancreatic duct stent. Previous analysis of the efficacy of ductal decompression following PD has been confounded by either including both the internal and external stent method or by small sample size. The aim of this meta-analysis was to analyze the efficacy of the external pancreatic duct stent method alone in preventing Post-Operative Pancreatic Fistula (POPF) formation and other complications in patients undergoing PD. \u0000Methods: A systematic literature search was conducted using the Medline, Cochrane Library, SCI, and EMBASE databases on all studies published from January 1970 to March 2012 reporting the peri-operative outcomes following PD. The primary end-point was the incidence of POPF formation in the presence of external pancreatic duct stent placement. Secondary outcomes considered included the incidence of post-operative mortality, Delayed Gastric Emptying (DGE), postoperative wound infection, operative time and blood loss, and length of hospital stay. \u0000Results: Four trials were included comprising 416 patients. There was a statistically significant decrease in the incidence of both any grade POPF formation (OR 0.37, 95% CI=0.23 to 0.58, P=0.0001) and clinically significant (grade B or C) POPF formation (OR 0.50, 95% CI=0.30 to 0.84, P=0.0009) in patients receiving an external pancreatic duct stent versus no stent following PD. Total length of hospital stay was also found to be shortened with the use of an external stent (SMD -0.39, 95% CI=-0.63 to -0.15, P=0.001). \u0000Conclusions: There is a decreased incidence of POPF formation following PD in patients receiving an external pancreatic duct stent versus patients receiving no stent. Total length of hospital stay was also found to be favorably affected by placement of an external pancreatic duct stent.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"91 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2014-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80498935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Current Guidelines for the Management of Branch Duct Intraductal Papillary Mucinous Neoplasms","authors":"B. Goh","doi":"10.4172/2165-7092.1000E134","DOIUrl":"https://doi.org/10.4172/2165-7092.1000E134","url":null,"abstract":"The management of pancreatic cystic neoplasms has been constantly evolving and changing over the past 2 decades [1-3]. This is mainly due to the rapid advancement of knowledge in this field resulting in particular: 1) the improved understanding of the natural history and biological behavior of the different pathological entities which comprise pancreatic cystic neoplasms and 2) more accurate preoperative diagnosis of these neoplasms as a result of a better understanding of their individual morphological characteristics on imaging and the introduction of newer diagnostic modalities such as endoscopic ultrasonography with fine needle aspirate (EUS-FNA) [2-4]. In general, the management approach has trended from that of aggressive surgical resection [5] to a more selective approach whereby most cystic neoplasms are now managed via surveillance [1,6-8]. Since the landmark paper by Compagno and Oertel [9]; the general consensus was that all mucinous neoplasms were potentially malignant or malignant and should be surgically resected whereas serous cystic neoplasms were benign and could be managed conservatively [2,10,11]. Subsequently, investigators recognized that mucinous neoplasms were actually composed of 2 distinct pathological entities i.e. mucinous cystic neoplasms (MCNs) and intraductal papillary mucinous neoplasms (IPMNs) [10,12,13]. More recently, it was recognized that IPMNs could be classified into branch-duct (BD), main-duct (MD) and mixed-duct types (MT) [14,15]. BD-IPMNs were found to be associated with a less aggressive biological behavior when compared to MD/MT-IPMN and many investigators have since demonstrated that selected BD-IPMNs could be managed conservatively [1,6,8,14-16].","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"83 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2014-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91106053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Pharmacological Options for Acute Pancreatitis: An Overview","authors":"R. Pezzilli","doi":"10.4172/2165-7092.1000142","DOIUrl":"https://doi.org/10.4172/2165-7092.1000142","url":null,"abstract":"Conclusions: The cornerstone of treatment is the control of pain and the restoration of circulation. Enteral nutrition is an essential therapeutic measure for the prevention of the catabolic state and bacterial translocation from the intestinal lumen to the pancreatic necrosis. Early refeeding is essential in patients recovering from an acute attack of acute pancreatitis and oral pancreatic extract supplementation should be given only when severe exocrine pancreatic insufficiency is demonstrated","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75814105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Towards A New Surgical Standard for the Treatment of Chronic Pancreatitis","authors":"R. Gruessner","doi":"10.4172/2165-7092.1000E132","DOIUrl":"https://doi.org/10.4172/2165-7092.1000E132","url":null,"abstract":"","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"132 1","pages":"1-2"},"PeriodicalIF":0.0,"publicationDate":"2013-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86637827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Curcumin: Ancient Drug, Modern Challenges, Malignant Pancreatitis","authors":"A. Shehzad","doi":"10.4172/2165-7092.1000E131","DOIUrl":"https://doi.org/10.4172/2165-7092.1000E131","url":null,"abstract":"Curcumin is the yellow biphenolic pigment isolated from turmeric, a curry spice that has been used as a therapeutic agent in human health system for centuries. Ever since then this dietary agent has attracted the interest of health practitioner and research oncologist for the treatment of various cancers [1]. In recent years the number of research publication on the therapeutic efficacy of curcumin has been expanding at a significant pace, as reflected by a web www.clinicaltrials.gov in November 2013 “curcumin” generating over 20 clinical trials in a wide variety of chronic diseases, particularly in cancer.","PeriodicalId":89708,"journal":{"name":"Pancreatic disorders & therapy","volume":"4 1","pages":"1-1"},"PeriodicalIF":0.0,"publicationDate":"2013-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90103171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}